Cardiology

Episodes 33-48 of 48

• 

  RestartResume

  Pulmonary Hypertension Management: Practice Trends and Updates

  RestartResume

  Pulmonary Hypertension Management: Practice Trends and Updates

  CME/CE Broadcast Replay

  Pulmonary Hypertension Management: Practice Trends and Updates

  1.00 credit

  • 

    

    Vallerie V. McLaughlin, MD

  • 

    

    Victor Moles, MD

  • 

    

    Ioana Preston, MD

  1.00 credit

• 

  RestartResume

  Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates

  RestartResume

  Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates

  CME/CE Broadcast Replay

  Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates

  1.00 credit

  • 

    

    Robert P. Frantz, MD, FACC

  • 

    

    Vallerie V. McLaughlin, MD

  • 

    

    Sonja Bartolomei, MD

  1.00 credit

• 

  RestartResume

  Pulmonary Hypertension: Comorbidities With PAH and Group 2 PH 

  RestartResume

  Pulmonary Hypertension: Comorbidities With PAH and Group 2 PH 

  CME/CE Broadcast Replay

  Pulmonary Hypertension: Comorbidities With PAH and Group 2 PH 

  1.00 credit

  • 

    

    Vallerie V. McLaughlin, MD

  • 

    

    Thomas Cascino, MD

  • 

    

    Bradley A. Maron, MD

  1.00 credit

• 

  RestartResume

  Updates From the 7th World Symposium Task Force

  RestartResume

  Updates From the 7th World Symposium Task Force

  CME/CE

  Updates From the 7th World Symposium Task Force

  1.00 credit

  • 

    

    Eric D. Austin, MD, MSCI

  • 

    

    Hilary M. DuBrock, MD

  • 

    

    H. James Ford, MD

  • 

    

    Gustavo A. Heresi, MD, MS

  • 

    

    Gergely Meszaros, JD, MSc

  • 

    

    Oksana A. Shlobin, MD

  • 

    

    Ioana Preston, MD

  • 

    

    Lucilla Piccari, MD, PhD

  1.00 credit

• 

  RestartResume

  The Heart’s Aftermath: IRI’s Impact on Cardiac Morbidity & Mortality

  RestartResume

  The Heart’s Aftermath: IRI’s Impact on Cardiac Morbidity & Mortality

  MinuteCE®

  The Heart’s Aftermath: IRI’s Impact on Cardiac Morbidity & Mortality

  0.50 program credits

  • 

    

    Manesh R. Patel, MD

  • 

    

    Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC

  0.50 program credits

• 

  RestartResume

  What’s on the Horizon for IRI Management?

  RestartResume

  What’s on the Horizon for IRI Management?

  MinuteCE®

  What’s on the Horizon for IRI Management?

  0.50 program credits

  • 

    

    Manesh R. Patel, MD

  • 

    

    Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC

  0.50 program credits

• 

  RestartResume

  Biomarkers of the Storm: Decoding IRI’s Signature

  RestartResume

  Biomarkers of the Storm: Decoding IRI’s Signature

  MinuteCE®

  Biomarkers of the Storm: Decoding IRI’s Signature

  0.50 program credits

  • 

    

    Manesh R. Patel, MD

  • 

    

    Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC

  0.50 program credits

• 

  RestartResume

  Unveiling the Reperfusion Paradox

  RestartResume

  Unveiling the Reperfusion Paradox

  MinuteCE®

  Unveiling the Reperfusion Paradox

  0.50 program credits

  • 

    

    Manesh R. Patel, MD

  0.50 program credits

• 

  MinuteCE®

  Reperfusion Paradox: The Hidden Threat in STEMI After PCI and the Quest for Effective Therapeutics

  0.50 credits 4 episodes

  • 

    

    Manesh R. Patel, MD

  • 

    

    Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC

  0.50 credits 4 episodes

• 

  RestartResume

  Risk stratification refinements with inclusion of hemodynamic variables at follow-up in patients with pulmonary arterial hypertension

  RestartResume

  Risk stratification refinements with inclusion of hemodynamic variables at follow-up in patients with pulmonary arterial hypertension

  MinuteCE®

  Risk stratification refinements with inclusion of hemodynamic variables at follow-up in patients with pulmonary arterial hypertension

  1.50 program credits

  • 

    

    Vallerie V. McLaughlin, MD

  1.50 program credits

• 

  RestartResume

  Update in Pediatric Pulmonary Hypertension

  RestartResume

  Update in Pediatric Pulmonary Hypertension

  MinuteCE®

  Update in Pediatric Pulmonary Hypertension

  1.50 program credits

  • 

    

    Richard Krasuski, MD

  1.50 program credits

• 

  RestartResume

  Vasoreactivity in Pulmonary Hypertension

  RestartResume

  Vasoreactivity in Pulmonary Hypertension

  MinuteCE®

  Vasoreactivity in Pulmonary Hypertension

  1.50 program credits

  • 

    

    Kelly Chin, MD, MSCA

  1.50 program credits

• 

  RestartResume

  Updates on Pulmonary Hypertension Clinical Trials

  RestartResume

  Updates on Pulmonary Hypertension Clinical Trials

  MinuteCE®

  Updates on Pulmonary Hypertension Clinical Trials

  1.50 program credits

  • 

    

    Vallerie V. McLaughlin, MD

  1.50 program credits

• 

  RestartResume

  The Promise of Sotatercept in PAH

  RestartResume

  The Promise of Sotatercept in PAH

  MinuteCE®

  The Promise of Sotatercept in PAH

  1.50 program credits

  • 

    

    Ioana Preston, MD

  1.50 program credits

• 

  RestartResume

  Macitentan Update: Impact on Management of Pulmonary Hypertension

  RestartResume

  Macitentan Update: Impact on Management of Pulmonary Hypertension

  MinuteCE®

  Macitentan Update: Impact on Management of Pulmonary Hypertension

  1.50 program credits

  • 

    

    Richard N. Channick, MD

  1.50 program credits

• 

  MinuteCE®

  Integrating Evidence for Improved Outcomes in PH

  1.50 credits 6 episodes

  • 

    

    Richard N. Channick, MD

  • 

    

    Vallerie V. McLaughlin, MD

  • 

    

    Ioana Preston, MD

  • 

    

    Kelly Chin, MD, MSCA

  • 

    

    Richard Krasuski, MD

  1.50 credits 6 episodes